Oncology CME

Credits: 0.75 CME / MOC / NCPD / CC
Medical Learning Institute, Inc.
Optimizing Care for High-Risk Myeloid Cancers: Interprofessional Team Insights From a Center of Excellence
Naval Daver, MD
April 14, 2021
Credits: 0.75 CME
Medical Learning Institute, Inc.
At the Nexus of Locoregional and Systemic Liver Cancer Therapy: A Multidisciplinary Tumor Board on Improving Outcomes in Intermediate to Advanced HCC
Matthew S. Johnson, MD, FSIR / Richard S. Finn, MD
April 14, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Precision Decisions in Genomic Testing and Targeted Treatment of NSCLC
Dara L. Aisner, MD, PhD / Joshua Bauml, MD
April 13, 2021
Credits: 1.00 CME / MOC / NCPD / ILNA / CPE
Medical Learning Institute, Inc.
Optimizing Patient Outcomes in RCC Through Safe and Efficacious Use of Immuno-Oncology and Targeted Approaches: Teaming Up to Mitigate and Manage Adverse Events and Maximize Survival
Brian I. Rini, MD, FASCO
April 12, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
The Path Forward for Immunotherapy in Resectable Melanoma: Principles and Perspectives on Using Immune-Based Adjuvant and Neoadjuvant Therapy
Jennifer Wargo, MD, MMSc
April 12, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
HER2 and HER3 Alterations as Therapeutic Targets of Increasing Significance in Solid Tumors: Implications for Pathology and Oncology Practice
Kurt A. Schalper, MD, PhD / Shanu Modi, MD
April 6, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
The Nuances of Immunotherapy Biomarker Testing in Solid Tumors: Unraveling Complexities and Overcoming Challenges to Improve Outcomes
Hossein Borghaei, DO, MS / Sanjay Mukhopadhyay, MD
April 5, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Conversations on the New Wave of Innovative Therapy in Follicular Lymphoma: Implications for Personalized Medicine
John M. Pagel, MD, PhD
April 5, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Rewriting the Rules for Early Cancer Screening: Case-Based Insight on Primary Care Principles for Using Blood-Based Screening Techniques
John J. Russell, MD
March 25, 2021
Credits: 0.50 CME / MOC / CE
Medical Learning Institute, Inc.
Innovative Blood-Based Screening in Cancer Care: State of the Science and Future Opportunities for Accelerating Cancer Diagnoses
Minetta C. Liu, MD
March 18, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
New Milestones and Changing Standards of Care in EGFR-Mutated NSCLC: Expanding the Benefits of Genomic Testing and EGFR-Targeted Therapy to Early-Stage Lung Cancer
March 9, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
RCC MasterClass and Clinical Consult: Remodeling the Treatment Algorithm With Novel Immune and Targeted Therapies
Toni K. Choueiri, MD
March 4, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Making the Right Moves in the Evolving Prostate Cancer Therapeutic Landscape: Expert Guidance on Treatment Sequencing and Selection for Effective Management Across the Disease Continuum
Robert Dreicer, MD, MS, MACP, FASCO
March 3, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Examining the State of the Science on New Therapies in Bladder Cancer: Perspectives on the Latest Developments Across the Disease Continuum
Professor Thomas Powles, MBBS, MRCP, MD
March 3, 2021
Credits: 1.00 CME
The Medical College of Wisconsin
How to Manage JAK Inhibition in Patients Undergoing HCT: Applying the Latest Clinical Evidence to Improve Patient Outcomes in Myelofibrosis
Ruben A. Mesa, MD, FACP
February 26, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Expanding the Benefits of Immuno-Oncology to More Patients With Solid Tumors Through Novel Rational Targets and Combinations
Jason J. Luke, MD, FACP
February 24, 2021
Credits: 1.00 CME
The Medical College of Wisconsin
New Perspectives in Acute and Chronic GVHD: Challenges and Opportunities for Improving Prophylaxis and Treatment With Novel Therapeutics
Corey Cutler, MD, MPH, FRCP(C) / Miguel-Angel Perales, MD
February 23, 2021
Credits: 1.00 CME
The Medical College of Wisconsin
Betting on CAR-T Cell Therapy: Expert Perspectives on Effective Integration Strategies and Achieving Improved Outcomes Across Hematologic Cancers
Michael R. Bishop, MD
February 18, 2021
Credits: 1.00 CME
The Medical College of Wisconsin
The Multiple Myeloma Workshop: Exploring the Convergence of Novel Therapeutic Platforms, Cell Therapy, and ASCT
Robert Z. Orlowski, MD, PhD
February 17, 2021
Credits: 1.00 CME
The Medical College of Wisconsin
Charting Progress in AML Care: A Clinical CaseBook on the Intersection of Novel Therapy and Allogeneic HCT
February 16, 2021
Credits: 1.25 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Changing the Game for Patients With ES-SCLC Through Multidisciplinary Collaboration: Best Practices to Optimize Immunotherapy-Based Approaches and Improve Patient Outcomes
Stephen V. Liu, MD
February 12, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
A New Dawn in the Therapeutic Management of Biliary Cancers: Integrating Precision Medicine With New and Emerging Targeted Strategies
Milind Javle, MD
February 11, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
How I Think, How I Treat: Remodeling the HCC Treatment Algorithm With New and Emerging Monotherapy, Combination, and Multimodal Approaches
Richard S. Finn, MD
February 9, 2021
Credits: 1.75 CME / MOC
Medical Learning Institute, Inc.
Taking Aim at GI Cancers: New Opportunities to Deliver Personalized Treatment With HER2 and Other Molecularly Targeted Therapies
Axel Grothey, MD
February 8, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Checkpoint Inhibition in Gastrointestinal Cancers: Recent Advances in Gastric, Esophageal, and Colorectal Cancers and Their Application in Clinical Practice
Manish A. Shah, MD, FASCO
February 3, 2021
Credits: 0.75 CME
Medical Learning Institute, Inc.
Selective Inhibition of Oncogenic Transcription and Other Novel Approaches in the Treatment of Small Cell Lung Cancer: An Illustrative Guide to Navigating the Evolving Treatment Landscape and Integrating Latest Treatment Modalities Into Clinical Care
Jacob Sands, MD
January 29, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
New Horizons in EGFR-Mutated NSCLC: Broadening the Impact of Precision Testing in the Context of an Expanding Treatment Landscape
Maria Arcila, MD
January 26, 2021
Credits: 0.70 CME
Purdue University
Changing the Treatment Story With Hormonal Therapy in Prostate Cancer: Challenges and Opportunities for Improving Care Across Disease Settings
Neal D. Shore, MD, FACS
December 30, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
A Visual Exploration of New Opportunities in Thyroid Cancer: Targeting RET Alterations to Optimize Outcomes
Marcia S. Brose, MD, PhD
December 30, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Targeting Ocular Toxicity in Multiple Myeloma: Opportunities for Ophthalmology-Oncology Collaboration
Sagar Lonial, MD, FACP
December 29, 2020

Pages